Direct signaling of TL1A-DR3 on fibroblasts induces intestinal fibrosis in vivo
Tumor necrosis factor-like cytokine 1A (TL1A, TNFSF15 ) is implicated in inflammatory bowel disease, modulating the location and severity of inflammation and fibrosis. TL1A expression is increased in inflamed mucosa and associated with fibrostenosing Crohn’s disease. Tl1a-overexpression in mice caus...
Saved in:
Published in | Scientific reports Vol. 10; no. 1; p. 18189 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
23.10.2020
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Tumor necrosis factor-like cytokine 1A (TL1A,
TNFSF15
) is implicated in inflammatory bowel disease, modulating the location and severity of inflammation and fibrosis. TL1A expression is increased in inflamed mucosa and associated with fibrostenosing Crohn’s disease. Tl1a-overexpression in mice causes spontaneous ileitis, and exacerbates induced proximal colitis and fibrosis. Intestinal fibroblasts express Death-receptor 3 (DR3; the only know receptor for TL1A) and stimulation with TL1A induces activation in vitro. However, the contribution of direct TL1A-DR3 activation on fibroblasts to fibrosis in vivo remains unknown. TL1A overexpressing naïve T cells were transferred into
Rag
−/−
,
Rag
−/−
mice lacking DR3 in all cell types (
Rag
−/−
Dr3
−/−
), or
Rag
−/−
mice lacking DR3 only on fibroblasts (
Rag
−/−
Dr3
∆Col1a2
) to induce colitis and fibrosis, assessed by clinical disease activity index, intestinal inflammation, and collagen deposition.
Rag
−/−
mice developed overt colitis with intestinal fibrostenosis. In contrast,
Rag
−/−
Dr3
−/−
demonstrated decreased inflammation and fibrosis. Despite similar clinical disease and inflammation as
Rag
−/−
, Rag
−/−
Dr3
∆Col1a2
exhibited reduced intestinal fibrosis and attenuated fibroblast activation and migration. RNA-Sequencing of TL1A-stimulated fibroblasts identified Rho signal transduction as a major pathway activated by TL1A and inhibition of this pathway modulated TL1A-mediated fibroblast functions. Thus, direct TL1A signaling on fibroblasts promotes intestinal fibrosis in vivo. These results provide novel insight into profibrotic pathways mediated by TL1A paralleling its pro-inflammatory effects. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 2045-2322 2045-2322 |
DOI: | 10.1038/s41598-020-75168-5 |